Home Pharmaceuticals Precision Medicine Market Size Forecasted to Reach 15.90% CAGR by 2033

Precision Medicine Market Size, Share & Trends Analysis Report By Ecosystem (Applied Sciences, Precision Diagnostics, Precision Therapeutics, Digital Health and Information Technology), By Application (Oncology, Neurology/psychiatry, Infectious diseases, Gastroenterology, Cardiovascular, Endocrinology, Rheumatology) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH2120DR
Last Updated : March 21, 2025
Author : Debashree Bora
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Precision Medicine Market Introduction
    2. By Ecosystem
      1. Introduction
        1. Ecosystem By Value
      2. Applied Sciences
        1. By Value
      3. Precision Diagnostics
        1. By Value
      4. Precision Therapeutics
        1. By Value
      5. Digital Health and Information Technology
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Neurology/psychiatry
        1. By Value
      4. Infectious diseases
        1. By Value
      5. Gastroenterology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrinology
        1. By Value
      8. Rheumatology
        1. By Value
    1. Introduction
    2. By Ecosystem
      1. Introduction
        1. Ecosystem By Value
      2. Applied Sciences
        1. By Value
      3. Precision Diagnostics
        1. By Value
      4. Precision Therapeutics
        1. By Value
      5. Digital Health and Information Technology
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Neurology/psychiatry
        1. By Value
      4. Infectious diseases
        1. By Value
      5. Gastroenterology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrinology
        1. By Value
      8. Rheumatology
        1. By Value
    4. U.S.
      1. By Ecosystem
        1. Introduction
          1. Ecosystem By Value
        2. Applied Sciences
          1. By Value
        3. Precision Diagnostics
          1. By Value
        4. Precision Therapeutics
          1. By Value
        5. Digital Health and Information Technology
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Oncology
          1. By Value
        3. Neurology/psychiatry
          1. By Value
        4. Infectious diseases
          1. By Value
        5. Gastroenterology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrinology
          1. By Value
        8. Rheumatology
          1. By Value
    5. Canada
    1. Introduction
    2. By Ecosystem
      1. Introduction
        1. Ecosystem By Value
      2. Applied Sciences
        1. By Value
      3. Precision Diagnostics
        1. By Value
      4. Precision Therapeutics
        1. By Value
      5. Digital Health and Information Technology
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Neurology/psychiatry
        1. By Value
      4. Infectious diseases
        1. By Value
      5. Gastroenterology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrinology
        1. By Value
      8. Rheumatology
        1. By Value
    4. U.K.
      1. By Ecosystem
        1. Introduction
          1. Ecosystem By Value
        2. Applied Sciences
          1. By Value
        3. Precision Diagnostics
          1. By Value
        4. Precision Therapeutics
          1. By Value
        5. Digital Health and Information Technology
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Oncology
          1. By Value
        3. Neurology/psychiatry
          1. By Value
        4. Infectious diseases
          1. By Value
        5. Gastroenterology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrinology
          1. By Value
        8. Rheumatology
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Ecosystem
      1. Introduction
        1. Ecosystem By Value
      2. Applied Sciences
        1. By Value
      3. Precision Diagnostics
        1. By Value
      4. Precision Therapeutics
        1. By Value
      5. Digital Health and Information Technology
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Neurology/psychiatry
        1. By Value
      4. Infectious diseases
        1. By Value
      5. Gastroenterology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrinology
        1. By Value
      8. Rheumatology
        1. By Value
    4. China
      1. By Ecosystem
        1. Introduction
          1. Ecosystem By Value
        2. Applied Sciences
          1. By Value
        3. Precision Diagnostics
          1. By Value
        4. Precision Therapeutics
          1. By Value
        5. Digital Health and Information Technology
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Oncology
          1. By Value
        3. Neurology/psychiatry
          1. By Value
        4. Infectious diseases
          1. By Value
        5. Gastroenterology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrinology
          1. By Value
        8. Rheumatology
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Ecosystem
      1. Introduction
        1. Ecosystem By Value
      2. Applied Sciences
        1. By Value
      3. Precision Diagnostics
        1. By Value
      4. Precision Therapeutics
        1. By Value
      5. Digital Health and Information Technology
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Neurology/psychiatry
        1. By Value
      4. Infectious diseases
        1. By Value
      5. Gastroenterology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrinology
        1. By Value
      8. Rheumatology
        1. By Value
    4. UAE
      1. By Ecosystem
        1. Introduction
          1. Ecosystem By Value
        2. Applied Sciences
          1. By Value
        3. Precision Diagnostics
          1. By Value
        4. Precision Therapeutics
          1. By Value
        5. Digital Health and Information Technology
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Oncology
          1. By Value
        3. Neurology/psychiatry
          1. By Value
        4. Infectious diseases
          1. By Value
        5. Gastroenterology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrinology
          1. By Value
        8. Rheumatology
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Ecosystem
      1. Introduction
        1. Ecosystem By Value
      2. Applied Sciences
        1. By Value
      3. Precision Diagnostics
        1. By Value
      4. Precision Therapeutics
        1. By Value
      5. Digital Health and Information Technology
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Neurology/psychiatry
        1. By Value
      4. Infectious diseases
        1. By Value
      5. Gastroenterology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrinology
        1. By Value
      8. Rheumatology
        1. By Value
    4. Brazil
      1. By Ecosystem
        1. Introduction
          1. Ecosystem By Value
        2. Applied Sciences
          1. By Value
        3. Precision Diagnostics
          1. By Value
        4. Precision Therapeutics
          1. By Value
        5. Digital Health and Information Technology
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Oncology
          1. By Value
        3. Neurology/psychiatry
          1. By Value
        4. Infectious diseases
          1. By Value
        5. Gastroenterology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrinology
          1. By Value
        8. Rheumatology
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Precision Medicine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Bristol-Myers Squibb Company
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina Inc.
    3. Pacific Biosciences of California Inc.
    4. AstraZeneca PLC
    5. Eli Lilly and Company
    6. Merck & Co. Inc.
    7. Premaitha Health plc
    8. QIAGEN N.V.
    9. Johnson and Johnson
    10. Asuragen Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global oncology precision medicine market size was estimated to be worth $49.4 billion in 2021, and it is expected to reach $ 124.84 billion by 2030, expanding at a CAGR of 10.85% from 2021 to 2030. The term precision medicine refers t
Buy Now
Global Report
Personalized Medicine Market Size The global personalized medicine market size was valued at USD 64.15 billion in 2022 and is projected to reach USD 166.78 billion by 2031, with a CAGR of 11.2 % during the forecast period 20
Buy Now
Global Report
Precision Farming Market Size The global Precision Farming Market Size was valued at USD 12.70 billion in 2024 and is projected to reach from USD 14.18 billion in 2025 to USD 34.11 billion by 2033, growing at a CAGR of1
Buy Now
Global Report
Precision Guided Munition Market Size The global Precision Guided Munition Market size was valued at USD 38.10 billion in 2024 and is projected to reach from USD 40.19 billion in 2025 to USD 61.69 billion by 2033, growing at
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :